Table 1.
General characteristics of the study population.
| Characteristic | Vaccine | Total | ||||
|---|---|---|---|---|---|---|
| BNT162b2 | Ad5-nCoV | n = 115 | % | |||
| n | % | n | % | |||
| Sex | ||||||
| Male | 15 | 24.6 | 25 | 46.3 | 40 | 34.8 |
| Female | 46 | 75.4 | 29 | 53.7 | 75 | 65.2 |
| Comorbidities | ||||||
| Diabetes | 11 | 18.0 | 3 | 5.6 | 14 | 12.2 |
| Arterial hypertension | 24 | 39.3 | 2 | 3.7 | 26 | 22.6 |
| Cancer | 3 | 4.9 | 0 | 0 | 3 | 2.6 |
| Allergies | 13 | 21.3 | 11 | 20.4 | 24 | 20.9 |
| Chronic kidney disease | 1 | 1.6 | 0 | 0 | 1 | 0.9 |
| Chronic liver disease | 1 | 1.6 | 0 | 0 | 1 | 0.9 |
| Immunosuppression | 2 | 3.3 | 2 | 3.7 | 4 | 3.5 |
| Obesity and overweight | 15 | 24.6 | 12 | 22.2 | 27 | 23.5 |
| Other chronic disease | 11 | 18.0 | 3 | 5.6 | 14 | 12.2 |